These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 604108)

  • 21. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization.
    Marshall D; Sealy R; Sangster M; Coleclough C
    J Immunol; 1999 Nov; 163(9):4673-82. PubMed ID: 10528164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative antigenicity and immunogenicity of A/USSR/77 influenza vaccines in normal and primed mice.
    McLaren C; Grubbs GE; Staton E; Barthlow W; Quinnan G; Ennis FA
    Infect Immun; 1980 Apr; 28(1):171-7. PubMed ID: 7380562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human responses to purified surface antigen invluenza vaccine (Fluvirin).
    Stones PB; Furminger IG; Kerr J
    Dev Biol Stand; 1977 Jun 1-3; 39():239-42. PubMed ID: 604103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of the immune response to influenza virus subunit vaccines.
    Webster RG; Glezen WP; Hannoun C; Laver WG
    J Immunol; 1977 Dec; 119(6):2073-7. PubMed ID: 915292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
    Tamura S; Tanimoto T; Kurata T
    Jpn J Infect Dis; 2005 Aug; 58(4):195-207. PubMed ID: 16116250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in antibody responses of mice to intranasal or intraperitoneal immunization with influenza A virus and vaccination with subunit influenza vaccine.
    Fislová T; Sládková T; Gocník M; Mucha V; Varecková E; Kostolanský F
    Acta Virol; 2005; 49(4):243-50. PubMed ID: 16402681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related heterologous antibody responses to influenza virus vaccination.
    Noble GR; Kaye HS; Kendal AP; Dowdle WR
    J Infect Dis; 1977 Dec; 136 Suppl():S686-92. PubMed ID: 606792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivated influenza A/New Jersey/76 vaccines in children: results of a mult-center trial.
    Wright PF; Vaughn WK; Thompson J; Sell SH; Karzon DT
    Dev Biol Stand; 1977 Jun 1-3; 39():309-13. PubMed ID: 342312
    [No Abstract]   [Full Text] [Related]  

  • 31. Relevance of the immunoprecipitation assay to human immunogenicity of influenza vaccines.
    Brandon FB; Havlick MJ; Shillis JL
    Dev Biol Stand; 1977 Jun 1-3; 39():179-85. PubMed ID: 414949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose trials of monovalent A/New Jersey/76 (Hsw1N1) influenza virus vaccine in children in Durham, North Carolina.
    Gutman LT; Wilfert CM; Idriss ZH; Schmidt E; Andrews S; Katz SL
    J Infect Dis; 1977 Dec; 136 Suppl():S575-8. PubMed ID: 606774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibodies against A/USSR/90/77 (H1N1) following vaccination with A/New Jersey/76 (Hsw 1 N1)-vaccine].
    Pressler K; Schenk D
    MMW Munch Med Wochenschr; 1978 Feb; 120(5):116. PubMed ID: 304967
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibody responses to influenza vaccines containing A/New Jersey/8/76.
    Feery BJ; Hampson AW; Rodda SJ; Evered MG
    Aust J Exp Biol Med Sci; 1978 Dec; 56(6):639-47. PubMed ID: 752306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responses of elderly and chronically ill subjects to bivalent influenza A/New Jersey/8/76 (Hsw1N1)-A/Victoria/3/75 (H3N2) vaccines.
    Douglas RG; Bentley DW; Brandriss MW
    J Infect Dis; 1977 Dec; 136 Suppl():S526-32. PubMed ID: 342625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuraminidase content of influenza vaccines and neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations.
    Kendal AP; Noble GR; Dowdle WR
    J Infect Dis; 1977 Dec; 136 Suppl():S415-24. PubMed ID: 606765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral antigens and impurities in influenza vaccines. Evaluation by immunoelectrophoretic methods.
    Liehl E; Bachmayer H
    Dev Biol Stand; 1977 Jun 1-3; 39():163-8. PubMed ID: 564309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further investigations on the antioncogenic activity of A/PR8/34 (HON1)- influenza virus on polyoma virus induced tumors in newborn Wistar rats.
    Desselberger U; Drescher J; Georgii A; Ostertag H
    Zentralbl Bakteriol Orig A; 1978 Jun; 240(4):411-23. PubMed ID: 211752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Summary of clinical trials of influenza virus vaccines in adults.
    Parkman PD; Hopps HE; Rastogi SC; Meyer HM
    J Infect Dis; 1977 Dec; 136 Suppl():S722-30. PubMed ID: 606797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody response of young adults to experimental influenza A/New Jersey/76 virus vaccines.
    Meiklejohn G; Eickhoff TC; Graves P
    J Infect Dis; 1977 Dec; 136 Suppl():S456-9. PubMed ID: 606766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.